Drug Profile
Naloxone/tianeptine - Tonix Pharmaceuticals
Alternative Names: Tianeptine; Tianeptine hemioxalate extended-release tablets; Tianeptine oxalate and naloxone controlled-release tablet - Tonix Pharmaceuticals; Tianeptine oxalate controlled-release - Tonix Pharmaceuticals; TNX 601; TNX-601 CR; TNX-601 ERLatest Information Update: 02 Nov 2023
Price :
$50
*
At a glance
- Originator Tonix Pharmaceuticals Holding Corp
- Developer Rho; Tonix Pharmaceuticals Holding Corp
- Class Antidotes; Anxiolytics; Benzofurans; Drug withdrawal therapies; Isoquinolines; Ketones; Morphinans; Nootropics; Small molecules; Thiazepines; Tricyclic antidepressants
- Mechanism of Action Glutamate receptor modulators; Opioid mu receptor agonists; Opioid mu receptor antagonists; Peroxisome proliferator-activated receptor agonists; Serotonin uptake stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Cognition disorders; Major depressive disorder; Post-traumatic stress disorders